BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 59 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,588 | +830.6% | 46,800 | +836.0% | 0.05% | +1200.0% |
| Q2 2023 | $493 | -91.7% | 5,000 | -91.5% | 0.00% | -94.2% |
| Q1 2023 | $5,967 | -99.9% | 58,800 | +31.5% | 0.07% | +130.0% |
| Q3 2020 | $4,704,000 | +284.0% | 44,720 | +347.2% | 0.03% | +200.0% |
| Q2 2020 | $1,225,000 | +16.7% | 10,000 | 0.0% | 0.01% | 0.0% |
| Q1 2020 | $1,050,000 | -0.8% | 10,000 | 0.0% | 0.01% | 0.0% |
| Q4 2019 | $1,059,000 | +7.5% | 10,000 | 0.0% | 0.01% | +25.0% |
| Q3 2019 | $985,000 | -32.4% | 10,000 | -28.6% | 0.01% | -20.0% |
| Q2 2019 | $1,457,000 | +42.0% | 14,000 | +40.0% | 0.01% | +11.1% |
| Q1 2019 | $1,026,000 | +2.9% | 10,000 | 0.0% | 0.01% | 0.0% |
| Q4 2018 | $997,000 | -48.2% | 10,000 | -44.4% | 0.01% | -35.7% |
| Q3 2018 | $1,923,000 | +5.5% | 18,000 | 0.0% | 0.01% | -12.5% |
| Q2 2018 | $1,823,000 | +7.9% | 18,000 | 0.0% | 0.02% | +14.3% |
| Q1 2018 | $1,690,000 | +69.7% | 18,000 | +80.0% | 0.01% | +55.6% |
| Q4 2017 | $996,000 | -34.5% | 10,000 | -33.3% | 0.01% | -30.8% |
| Q3 2017 | $1,520,000 | – | 15,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SHENKMAN CAPITAL MANAGEMENT INC | 16,732,000 | $16,408,385 | 1.23% |
| SONA ASSET MANAGEMENT (US) LLC | 23,125,000 | $22,451,923 | 0.93% |
| SSI INVESTMENT MANAGEMENT LLC | 8,726,000 | $8,464,220 | 0.69% |
| PFM Health Sciences, LP | 15,000,000 | $14,587,500 | 0.69% |
| RWC Asset Management LLP | 10,000,000 | $9,709,000 | 0.63% |
| Sonora Investment Management Group, LLC | 6,245,000 | $6,108,182 | 0.52% |
| Paloma Partners Management Co | 10,006,000 | $9,733,285 | 0.34% |
| MACKAY SHIELDS LLC | 9,891,000 | $9,594,270 | 0.26% |
| PALISADE CAPITAL MANAGEMENT, LP | 8,704,000 | $8,455,066 | 0.24% |
| Centiva Capital, LP | 10,000,000 | $9,716,288 | 0.21% |